Canagliflozin Impurities refer to the substances or compounds that may be present alongside the active pharmaceutical ingredient, Canagliflozin, in a drug product. These impurities may arise from various sources such as the synthesis process, degradation of the drug, or from the raw materials used in the manufacturing process. It is important to monitor and control these impurities as they can affect the efficacy and safety of the drug product.